NCT06345183 2025-11-06Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) PatientsBristol-Myers SquibbCompleted327 enrolled
NCT07159191 2025-09-08Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell CarcinomaPeking Union Medical College HospitalPhase 2 Not yet recruiting30 enrolled